CERo Therapeutics Holdings (CERO)
NASDAQ:CERO
US Market
Holding CERO?
Track your performance easily

CERo Therapeutics Holdings (CERO) Income Statement

127 Followers

CERo Therapeutics Holdings Income Statement

Last quarter (Q ), CERo Therapeutics Holdings's total revenue was $―, a decrease of ― from the same quarter last year. In Q, CERo Therapeutics Holdings's net income was $-2.45M. See CERo Therapeutics Holdings’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21
Total Revenue
----
Cost of Revenue
----
Gross Profit
----
Operating Expense
$ 7.47M$ 2.93M$ 2.91M$ 332.03K
Operating Income
$ -7.51M$ -2.93M$ -2.91M$ -171.38K
Net Non Operating Interest Income Expense
$ 383.01K$ 491.57K$ -142.12K-
Other Income Expense
$ -3.35M---
Pretax Income
$ -4.42M$ -2.44M$ -11.83M$ -332.42K
Tax Provision
$ 94.82K$ 94.82K$ 599.16K$ -16.87K
Earnings From Equity Interest Net Of Tax
----
Net Income Common Stockholders
$ -4.50M$ -2.54M$ -11.83M$ 20.95M
Basic EPS
$ -0.46$ -0.39$ -0.06$ 4.12
Diluted EPS
$ -0.46$ -0.39$ -0.06$ 4.12
Basic Average Shares
$ 44.74M$ 6.53M$ 22.49M$ 9.65M
Diluted Average Shares
$ 46.91M$ 6.53M$ 22.49M$ 9.65M
Dividend Per Share
----
Total Operating Income As Reported
----
Reported Normalized Basic E P S
----
Reported Normalized Diluted E P S
----
Rent Expense Supplemental
----
Total Expenses
$ 7.49M$ 2.93M$ 11.97M$ 332.03K
Net Income From Continuing And Discontinued Operation
$ -4.50M$ -2.54M$ -11.83M$ -150.69K
Normalized Income
$ -3.84M$ -1.78M$ -54.17K-
Interest Expense
----
EBIT
$ -4.46M$ -2.44M$ -11.97M$ -332.42K
EBITDA
$ -4.27M$ -2.44M$ -10.90M$ -332.42K
Currency in USD

CERo Therapeutics Holdings Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis